13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. RICHMAN ERIC I

RICHMAN ERIC I

CIK: 0001313876•CHIEF EXECUTIVE OFFICER
OfficerDirector
Primary company: PHARMATHENE, INC (PIP)

RICHMAN ERIC I is a corporate insider (CHIEF EXECUTIVE OFFICER) at PHARMATHENE, INC (PIP) filing SEC Form 4 transactions. 115 transactions across 5 companies, totaling $336,286 in purchases and $750,466 in sales. Source: SEC EDGAR.

Total Transactions
115
Total Buy Value
$336K
Total Sell Value
$750K
Net Activity
$-414K
Last Transaction
Jun 2025
Companies
5

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Gain Therapeutics, Inc.
GANX
Award15,000--15,000
6/24/2025
Filed: 6/25/2025
Filing →
Gain Therapeutics, Inc.
GANX
Purchase12,000$1.21$15K289,629
7/1/2024
Filed: 7/1/2024
Filing →
Gain Therapeutics, Inc.
GANX
Purchase5,000$1.23$6K277,629
7/1/2024
Filed: 7/1/2024
Filing →
Gain Therapeutics, Inc.
GANX
Award15,000--15,000
6/24/2024
Filed: 6/26/2024
Filing →
Gain Therapeutics, Inc.
GANX
Exercise54,900$0.00$00
9/20/2023
Filed: 9/22/2023
Filing →
Gain Therapeutics, Inc.
GANX
Exercise54,900--272,629
9/20/2023
Filed: 9/22/2023
Filing →
Gain Therapeutics, Inc.
GANX
Award54,900$0.00$054,900
9/20/2022
Filed: 9/22/2022
Filing →
Gain Therapeutics, Inc.
GANX
Award329,400$0.00$0329,400
9/20/2022
Filed: 9/22/2022
Filing →
NeuBase Therapeutics, Inc.
NBSE
Award37,600$0.00$037,600
9/9/2022
Filed: 9/12/2022
Filing →
Gain Therapeutics, Inc.
GANX
Purchase2,482$2.58$6K217,729
5/25/2022
Filed: 5/27/2022
Filing →
Gain Therapeutics, Inc.
GANX
Purchase9,256$2.83$26K215,247
5/20/2022
Filed: 5/23/2022
Filing →
Gain Therapeutics, Inc.
GANX
Purchase4,000$2.71$11K205,991
5/19/2022
Filed: 5/23/2022
Filing →
Gain Therapeutics, Inc.
GANX
Purchase4,922$7.87$39K216,820
8/16/2021
Filed: 4/21/2022
Filing →
NeuBase Therapeutics, Inc.
NBSE
Purchase1,000$1.62$2K44,960
3/4/2022
Filed: 3/7/2022
Filing →
NeuBase Therapeutics, Inc.
NBSE
Purchase1,300$1.72$2K43,960
3/3/2022
Filed: 3/7/2022
Filing →
NeuBase Therapeutics, Inc.
NBSE
Purchase1,580$1.58$2K42,660
3/1/2022
Filed: 3/7/2022
Filing →
NeuBase Therapeutics, Inc.
NBSE
Award38,135$0.00$038,135
8/19/2021
Filed: 9/17/2021
Filing →
Gain Therapeutics, Inc.
GANX
Exercise4,922$7.87$39K216,820
8/16/2021
Filed: 8/17/2021
Filing →
NeuBase Therapeutics, Inc.
NBSE
Purchase5,000$5.00$25K41,080
4/26/2021
Filed: 4/27/2021
Filing →
NeuBase Therapeutics, Inc.
NBSE
Award14,634$0.00$014,634
9/9/2020
Filed: 9/11/2020
Filing →
Gain Therapeutics, Inc.
GANX
Type
Award
Shares
15,000
Price
-
Value
-
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
12,000
Price
$1.21
Value
$15K
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
5,000
Price
$1.23
Value
$6K
Gain Therapeutics, Inc.
GANX
Type
Award
Shares
15,000
Price
-
Value
-
Gain Therapeutics, Inc.
GANX
Type
Exercise
Shares
54,900
Price
$0.00
Value
$0
Gain Therapeutics, Inc.
GANX
Type
Exercise
Shares
54,900
Price
-
Value
-
Gain Therapeutics, Inc.
GANX
Type
Award
Shares
54,900
Price
$0.00
Value
$0
Gain Therapeutics, Inc.
GANX
Type
Award
Shares
329,400
Price
$0.00
Value
$0
NeuBase Therapeutics, Inc.
NBSE
Type
Award
Shares
37,600
Price
$0.00
Value
$0
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
2,482
Price
$2.58
Value
$6K
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
9,256
Price
$2.83
Value
$26K
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
4,000
Price
$2.71
Value
$11K
Gain Therapeutics, Inc.
GANX
Type
Purchase
Shares
4,922
Price
$7.87
Value
$39K
NeuBase Therapeutics, Inc.
NBSE
Type
Purchase
Shares
1,000
Price
$1.62
Value
$2K
NeuBase Therapeutics, Inc.
NBSE
Type
Purchase
Shares
1,300
Price
$1.72
Value
$2K
NeuBase Therapeutics, Inc.
NBSE
Type
Purchase
Shares
1,580
Price
$1.58
Value
$2K
NeuBase Therapeutics, Inc.
NBSE
Type
Award
Shares
38,135
Price
$0.00
Value
$0
Gain Therapeutics, Inc.
GANX
Type
Exercise
Shares
4,922
Price
$7.87
Value
$39K
NeuBase Therapeutics, Inc.
NBSE
Type
Purchase
Shares
5,000
Price
$5.00
Value
$25K
NeuBase Therapeutics, Inc.
NBSE
Type
Award
Shares
14,634
Price
$0.00
Value
$0
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market